{"id":"https://openalex.org/W4367602629","doi":"https://doi.org/10.1158/1557-3125.ras23-b033","title":"Abstract B033: Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers","display_name":"Abstract B033: Wild-type RAS signaling is an essential therapeutic target in RAS-mutated cancers","publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4367602629","doi":"https://doi.org/10.1158/1557-3125.ras23-b033"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3125.ras23-b033","doi":"https://doi.org/10.1158/1557-3125.ras23-b033","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3125.ras23-b033","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055187581","display_name":"Nancy E. Sealover","orcid":"https://orcid.org/0000-0002-6463-5836","observed_orcids":["https://orcid.org/0000-0002-6463-5836"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Sealover","raw_affiliation_strings":["1USUHS, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1USUHS, Bethesda, MD","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064710374","display_name":"Bridget A. Finniff","orcid":"https://orcid.org/0009-0004-9331-9535","observed_orcids":["https://orcid.org/0009-0004-9331-9535"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bridget Finniff","raw_affiliation_strings":["1USUHS, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1USUHS, Bethesda, MD","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051052453","display_name":"Robert L. Kortum","orcid":"https://orcid.org/0000-0002-1634-4882","observed_orcids":["https://orcid.org/0000-0002-1634-4882"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Kortum","raw_affiliation_strings":["1USUHS, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1USUHS, Bethesda, MD","institution_ids":["https://openalex.org/I148314036"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I148314036"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"21","issue":"5_Supplement","first_page":"B033","last_page":"B033"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9003999829292297,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9003999829292297,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.08229999989271164,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.00860000029206276,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kras-g12c","display_name":"KRAS G12C","score":0.7860000133514404},{"id":"https://openalex.org/keywords/hras","display_name":"HRAS","score":0.8130000233650208},{"id":"https://openalex.org/keywords/raf-mek-erk-pathway","display_name":"Raf/MEK/ERK pathway","score":0.8399999737739563},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9879999756813049},{"id":"https://openalex.org/keywords/negative-feedback-control","display_name":"negative feedback control","score":0.6100000143051147},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-signaling","display_name":"receptor tyrosine kinase signaling","score":0.7459999918937683},{"id":"https://openalex.org/keywords/tipifarnib","display_name":"tipifarnib","score":0.8840000033378601},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8999999761581421},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.9789999723434448},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7250000238418579},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6520000100135803},{"id":"https://openalex.org/keywords/so","display_name":"SO","score":0.3799999952316284},{"id":"https://openalex.org/keywords/ras-effectors","display_name":"Ras effectors","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C1167327","wikidata":"https://www.wikidata.org/wiki/Q14884140","display_name":"HRAS","level":5,"score":0.9688723087310791},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.8355557918548584},{"id":"https://openalex.org/C127812441","wikidata":"https://www.wikidata.org/wiki/Q4774319","display_name":"Anti-apoptotic Ras signalling cascade","level":4,"score":0.7114815711975098},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.6823959946632385},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6308352947235107},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5947824716567993},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5908728241920471},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4466516971588135},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.43883898854255676},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.42608579993247986},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4178081750869751},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.416952908039093},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30745285749435425},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.29179492592811584},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07621368765830994},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3125.ras23-b033","doi":"https://doi.org/10.1158/1557-3125.ras23-b033","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1557-3125.ras23-b033","pdf_url":null,"source":{"id":"https://openalex.org/S192067876","display_name":"Molecular Cancer Research","issn_l":"1541-7786","issn":["1541-7786","1557-3125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282963641","https://openalex.org/W4393096028","https://openalex.org/W4414264357","https://openalex.org/W4409627081","https://openalex.org/W2076987456","https://openalex.org/W2120492882","https://openalex.org/W4390915461","https://openalex.org/W2896658886","https://openalex.org/W2025169031","https://openalex.org/W2566377242"],"abstract_inverted_index":{"Abstract":[0],"Single-agent":[1],"targeting":[2,58],"of":[3,21,41,93,127,135,176,231,259,289],"RAS-mutated":[4,52,154,265,284],"cancers":[5,53,285],"using":[6],"RAF/MEK/ERK":[7],"or":[8,250],"PI3K/AKT":[9],"pathway":[10,16],"inhibitors":[11,207,215,223,230],"is":[12,35,145,278],"ineffective;":[13],"blocking":[14],"one":[15],"relieves":[17,119],"negative":[18,120],"feedback":[19,121],"control":[20],"RTK":[22],"signaling":[23,144,202,218,243,277],"and":[24,32,95,141,186,192,203,219,234,244],"hyperactivates":[25],"parallel":[26],"effector":[27,86],"pathways.":[28],"While":[29],"combined":[30],"MEK":[31,206,217],"PI3K":[33,96,110,201,222],"inhibition":[34,77,118,175],"effective":[36],"in":[37,208,224,247,283],"preclinical":[38],"models,":[39],"toxicity":[40],"this":[42],"combination":[43],"prevents":[44],"its":[45],"clinical":[46,260],"use.":[47],"Alternative":[48],"strategies":[49],"for":[50,262],"treating":[51],"are":[54],"essential.":[55],"Therapeutics":[56],"directly":[57],"mutated":[59,172],"RAS":[60,76,85,88,117,129,140,143,160,167,177,183,233,235,242,276],"proteins":[61,89],"have":[62],"the":[63,136,257,290],"potential":[64],"to":[65,124,147,152,189],"spare":[66],"normal":[67],"cellular":[68],"function":[69],"thereby":[70],"lessening":[71],"overall":[72],"toxicity.":[73],"Unfortunately,":[74],"direct":[75],"as":[78],"a":[79],"monotherapy":[80],"does":[81],"not":[82],"fully":[83],"block":[84],"signaling.":[87,130],"show":[90],"differential":[91],"activation":[92],"RAF":[94,101],"pathways:":[97],"KRAS":[98,193],"potently":[99],"activates":[100,104,109,113],"but":[102,111],"poorly":[103,112,169,180],"PI3K,":[105],"whereas":[106],"HRAS":[107,191,197],"effectively":[108],"RAF.":[114],"Further,":[115,174],"mutant":[116,139,162,182,190,196,232],"controls":[122],"leading":[123],"rapid":[125],"hyperactivation":[126],"RTK\u2212WT":[128,142],"A":[131],"more":[132],"comprehensive":[133],"understanding":[134],"interplay":[137],"between":[138,229],"essential":[146,280],"developing":[148],"rational":[149],"therapeutic":[150,281],"approaches":[151],"treat":[153],"cancers.":[155,266],"We":[156],"found":[157],"that":[158],"WT":[159],"enhanced":[161],"RAS-driven":[163],"transformation":[164],"by":[165,171,181],"activating":[166],"effectors":[168,178,236],"engaged":[170],"RAS.":[173],"activated":[179],"synergized":[184,204,220],"with":[185,205,221,264],"limited":[187],"resistance":[188],"inhibitors.":[194],"The":[195],"inhibitor":[198],"tipifarnib":[199],"blocked":[200,216],"HRAS-mutated":[209],"cancer":[210],"cell":[211,226],"lines;":[212],"covalent":[213],"KRASG12C":[214],"KRASG12C-mutated":[225],"lines.":[227],"Synergy":[228],"was":[237,245],"dependent":[238],"on":[239],"intact":[240],"RTK/WT":[241],"lost":[246],"both":[248],"RASless":[249],"SOSless":[251],"MEFs.":[252],"These":[253],"results":[254],"should":[255],"inform":[256],"design":[258],"trials":[261],"patients":[263],"Citation":[267],"Format:":[268],"Nancy":[269],"Sealover,":[270],"Bridget":[271],"Finniff,":[272],"Robert":[273],"Kortum.":[274],"Wild-type":[275],"an":[279],"target":[282],"[abstract].":[286],"In:":[287],"Proceedings":[288],"AACR":[291],"Special":[292],"Conference:":[293],"Targeting":[294],"RAS;":[295],"2023":[296],"Mar":[297],"5-8;":[298],"Philadelphia,":[299],"PA.":[300],"Philadelphia":[301],"(PA):":[302],"AACR;":[303],"Mol":[304],"Cancer":[305],"Res":[306],"2023;21(5_Suppl):Abstract":[307],"nr":[308],"B033.":[309]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-05-02T00:00:00"}